Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicrobial compound BDM-I.... Read more
Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug tranylcypromine (TCP)... Read more
Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III... Read more
Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innovation Network Corporation... Read more
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approval for CardioCel,... Read more
Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed a research collaboration... Read more
Singapore: For glaucoma patients, taking daily medication will soon become a thing of the past. With Nanyang Technological University's... Read more
Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatments for patients... Read more
Recent promising data on drug approvals in 2011 shows that there were 35 new molecular entities (NME) approved by the FDA. This is the largest... Read more
Survey Box